Asahi Kasei

Limited research has been performed on the downstream processing of nano-co-crystal suspensions into solid oral dosage forms. The objectives of...

A novel approach for preparing drug-containing particles (DCPs) with controlled size distribution and high drug loading was developed using melt...

OBJECTIVE CEOLUSTM UF-711 is highly compactible and flowing microcrystalline cellulose (MCC). While UF-711 has over 1.5 times the compactibility of...

Assessment and understanding of changes in particle size of active pharmaceutical ingredients (API) and excipients as a function of solid...

Developing a robust roller compaction process can be challenging, due to the diversity in process parameters and material properties of...

AsahiKASEI is pleased to announce the launch of our brand new website! We provide an easy way to learn about...

OBJECTIVE CEOLUSTM UF-702 is the most flowable microcrystalline cellulose (MCC). While UF-702 has higher compactibility than standard grade PH-102, it...

OBJECTIVE When large-size tablets are coated, there are often problems of tablet surface abrasion and tablet weight loss due to...

Optimizing a product's disintegration and dissolution profile is a priority in the formulation development of pharmaceuticals. Read on to discover...

Asahi Kasei's pharmaceutical excipients CEOLUS™ offers a wide range of solutions to many problems facing the industry, including: Significant Tablet Size...